Literature DB >> 8273666

MR lymphography with superparamagnetic iron nanoparticles in rats: pathologic basis for contrast enhancement.

R Guimaraes1, O Clément, J Bittoun, F Carnot, G Frija.   

Abstract

OBJECTIVE: The purpose of this study in rodents was to determine the pathologic basis for enhancement patterns of hyperplastic and tumours lymph nodes shown by MR lymphography after IV injection of superparamagnetic iron oxide nanoparticles (AMI-227).
MATERIALS AND METHODS: Hyperplastic and tumorous lymph nodes were imaged in vivo at 1.5 T 1 day after IV administration of AMI-227 (40-200 mumol Fe/kg) to rats. Inguinal and axillary lymph nodes were surgically resected, and in vitro imaging was done by using the same magnet with a prototype coil that allowed a pixel size of 70 x 230 microns. Imaging findings were correlated with histologic findings and iron staining of the nodes.
RESULTS: With all sequences, at doses of 80 mumol Fe/kg or higher, the signal intensity of hyperplastic nodes was lower than on unenhanced images. The same pattern was seen in the remaining normal tissue of tumourous lymph nodes. This T2* effect was a result of clustered particles inside macrophages in the lymphatic sinuses. At doses of 200 mumol/kg, the tumor itself consistently showed an increase in signal intensity on T1-weighted images. This T1 effect probably resulted from particles leaking into the interstitial spaces of the tumor.
CONCLUSION: After IV injection of superparamagnetic nanoparticles, a decrease in signal intensity indicates active uptake of particles into macrophages, whereas an increase in signal intensity indicates altered capillary permeability in tumor. These findings in rats may prove to be clinically useful in the future for differentiating benign from malignant enlarged lymph nodes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8273666     DOI: 10.2214/ajr.162.1.8273666

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  13 in total

1.  In re: histological and morphologic comparison of experimental aneurysms with human intracranial aneurysms.

Authors:  W E Stehbens
Journal:  AJNR Am J Neuroradiol       Date:  2000-10       Impact factor: 3.825

Review 2.  Imaging the lymphatic system: possibilities and clinical applications.

Authors:  Olivier Clément; Alain Luciani
Journal:  Eur Radiol       Date:  2004-03-09       Impact factor: 5.315

Review 3.  New imaging modalities in bladder cancer.

Authors:  Mansi A Saksena; Douglas M Dahl; Mukesh G Harisinghani
Journal:  World J Urol       Date:  2006-11       Impact factor: 4.226

4.  Characterization of carotid artery plaques with USPIO-enhanced MRI: assessment of inflammation and vascularity as in vivo imaging biomarkers for plaque vulnerability.

Authors:  Stephan Metz; Ambros J Beer; Marcus Settles; Jaroslav Pelisek; René M Botnar; Ernst J Rummeny; Peter Heider
Journal:  Int J Cardiovasc Imaging       Date:  2010-10-24       Impact factor: 2.357

Review 5.  Lymphotropic nanoparticle enhanced MRI for the staging of genitourinary tumors.

Authors:  Samdeep K Mouli; Lee C Zhao; Reed A Omary; C Shad Thaxton
Journal:  Nat Rev Urol       Date:  2010-01-19       Impact factor: 14.432

Review 6.  Defining the role of modern imaging techniques in assessing lymph nodes for metastasis in cancer: evolving contribution of PET in this setting.

Authors:  Thomas C Kwee; Sandip Basu; Drew A Torigian; Babak Saboury; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-01-12       Impact factor: 9.236

7.  Lymphatic biodistribution of polylactide nanoparticles.

Authors:  Eric J Chaney; Li Tang; Rong Tong; Jianjun Cheng; Stephen A Boppart
Journal:  Mol Imaging       Date:  2010-06       Impact factor: 4.488

8.  Evaluation of tumoral enhancement by superparamagnetic iron oxide particles: comparative studies with ferumoxtran and anionic iron oxide nanoparticles.

Authors:  P-Y Brillet; F Gazeau; A Luciani; B Bessoud; C-A Cuénod; N Siauve; J-N Pons; J Poupon; O Clément
Journal:  Eur Radiol       Date:  2005-02-23       Impact factor: 5.315

9.  Dose and scanning delay using USPIO for central nervous system macrophage imaging.

Authors:  V Dousset; C Gomez; K G Petry; C Delalande; J M Caille
Journal:  MAGMA       Date:  1999-08       Impact factor: 2.310

10.  Ferumoxtran-10-enhanced MR imaging of the bone marrow before and after conditioning therapy in patients with non-Hodgkin lymphomas.

Authors:  Stephan Metz; Stefanie Lohr; Marcus Settles; Ambros Beer; Klaus Woertler; Ernst J Rummeny; Heike E Daldrup-Link
Journal:  Eur Radiol       Date:  2005-11-12       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.